1309456-83-4Relevant articles and documents
A class of histone acetylase p300 inhibitors, and application thereof
-
Paragraph 0230-0231; 0235-0237, (2020/06/17)
The invention discloses a class of histone acetylase p300 inhibitors, and application thereof, and belongs to the technical field of medicinal chemistry. The invention discloses a compound representedby a formula (I), or a stereochemical isomer, a solvate or a pharmaceutically acceptable salt thereof. According to the invention, the compound can effectively inhibit the activity of histone acetylase p300 and can effectively inhibit the proliferation activity of various tumor cells; the compound is combined with a CDK4/6 inhibitor to play a synergistic role in inhibiting proliferation of tumorcells; and the compound has good application prospects in preparation of histone acetylase inhibitors, preparation of drugs for preventing and/or treating cancers, metabolic diseases, neurological diseases or inflammations, and combination of drugs.
Highly enantioselective partial hydrogenation of simple pyrroles: A facile access to chiral 1-pyrrolines
Wang, Duo-Sheng,Ye, Zhi-Shi,Chen, Qing-An,Zhou, Yong-Gui,Yu, Chang-Bin,Fan, Hong-Jun,Duan, Ying
supporting information; experimental part, p. 8866 - 8869 (2011/07/30)
A highly enantioselective Pd-catalyzed partial hydrogenation of simple 2,5-disubstituted pyrroles with a Bronsted acid as an activator has been successfully developed, providing chiral 2,5-disubstituted 1-pyrrolines with up to 92% ee.